Copenhagen, Denmark

Maria Kabisch

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Novo Nordisk A/s. Active years: 2024-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Maria Kabisch - Innovator in Medical Therapy

Introduction

Maria Kabisch is a prominent inventor based in Koebenhavn S, Denmark. She has made significant contributions to the field of medical therapy, particularly in weight management. Her innovative work has led to the development of a patent that addresses important health issues.

Latest Patents

Maria Kabisch holds a patent for "Semaglutide in medical therapy." This invention relates to the use of semaglutide for effective weight management. The patent highlights her commitment to advancing medical treatments that can improve the quality of life for many individuals.

Career Highlights

Maria is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. Her role at Novo Nordisk has allowed her to work on groundbreaking therapies that have the potential to change lives.

Collaborations

Throughout her career, Maria has collaborated with talented professionals, including Marianne Oelholm Larsen Groenning and Lars Endahl. These partnerships have fostered an environment of innovation and creativity, leading to the development of effective medical solutions.

Conclusion

Maria Kabisch is a remarkable inventor whose work in medical therapy exemplifies the impact of innovation on health and wellness. Her contributions, particularly in the area of weight management, continue to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…